Case File: United States ex rel. Crawford v. Independence Blue Cross
Case No.: 20-cv-5818 (listed in some databases as 2:20-cv-05818)
Court: U.S. District Court, Eastern District of Pennsylvania
Settlement Amount: $22,500,000
Whistleblower’s Share: $3,825,000
Announced: September 30, 2026
Period at Issue: Medicare payment years 2017 through 2021, according to the Justice Department
Status: Allegations only. There has been no determination of liability.
Imagine a nurse reviewing a stack of patient charts. Every time she finds a diagnosis the insurer hadn’t reported, it goes to Medicare for extra money. Every time she finds a diagnosis the insurer already reported that the chart doesn’t actually support, it gets left alone. According to the federal government, that is how one of Philadelphia’s biggest health insurers handled its Medicare Advantage paperwork for years.
Independence Blue Cross (IBX) has now agreed to pay $22.5 million to resolve those allegations, which the U.S. Attorney’s Office in Philadelphia announced on September 30, 2026. The company has not admitted wrongdoing, and the government says plainly that the claims are only allegations. Still, the way this case is built makes it a useful window into how Medicare Advantage billing works, and how it can go wrong.
A Quick Primer on How Medicare Advantage Pays
Medicare Advantage, also called Medicare Part C, lets people leave traditional Medicare and join a private health plan instead. Those plans are run by companies the government calls Medicare Advantage Organizations.
The federal Centers for Medicare & Medicaid Services (CMS) doesn’t pay these insurers per doctor visit. It pays a fixed monthly amount for each enrolled person, then adjusts that amount based on how sick the person is expected to be. Sicker patients are expected to cost more, so the insurer gets paid more for them.
To make that adjustment, CMS relies on diagnosis codes that the insurers themselves submit. That is the weak point in the system:
- The more serious the diagnoses on file, the higher the monthly payment
- The insurer controls much of the data that drives its own payment
- If a code is wrong, the insurer is supposed to withdraw it and pay the money back
What the Government Says IBX Did
According to the Justice Department, IBX ran what it called a “chart review” program for payment years 2017 through 2021. Nurse reviewers read through patients’ medical records and flagged every condition the charts supported. IBX then used the results to submit additional diagnosis codes to CMS and collect additional payments.
The government’s problem is with what happened to the other half of those results. The same reviews, it says, showed that some diagnosis codes IBX had already reported were not backed up by the charts. Those codes weren’t deleted or withdrawn, and the overpayments tied to them weren’t repaid.
In short, the allegations come down to three points:
- IBX submitted inaccurate and untruthful diagnosis data to CMS, which inflated its risk-adjusted payments
- IBX failed to withdraw the unsupported diagnoses and repay CMS once its own reviews exposed them
- IBX falsely certified in writing to CMS that the data it submitted was accurate and truthful
The government’s summary of the pattern is blunt. It says IBX used the chart reviews to find places where it could ask for more money, while ignoring the same reviews when they showed it had been overpaid.
The Whistleblower Behind the Case
This settlement didn’t begin with a government audit. It began with a lawsuit filed under the whistleblower provisions of the False Claims Act, a law that lets private individuals sue on the government’s behalf when they believe someone is cheating a federal program, and share in whatever the government recovers.
The case is captioned United States ex rel. Crawford v. Independence Blue Cross and was filed in federal court in Philadelphia in 2020, as the “20” in its case number shows. The person who brought it is a former IBX employee. Under the settlement, that whistleblower will receive $3,825,000, which works out to roughly 17 percent of the total.
In Their Own Words
The officials announcing the settlement framed it as a message to the entire Medicare Advantage industry, not just one insurer. U.S. Attorney David Metcalf said:
“The Medicare Advantage program depends on accurate data about patient health. When insurers inflate their profits and the government’s costs by submitting or failing to correct unsupported diagnoses, my office will continue to hold them accountable.”
Assistant Attorney General Brett A. Shumate, who leads the Justice Department’s Civil Division, put the size of the program in perspective:
“The government pays private insurers over $530 billion each year to care for Americans enrolled in Medicare Advantage. When insurers knowingly and improperly retain inflated payments based on inaccurate and untruthful diagnoses, we will hold them accountable whether they are a small regional plan or a large nationwide organization.”
Miranda L. Bennett, Acting Deputy Inspector General for Investigations at the Department of Health and Human Services’ Office of Inspector General, which supported the investigation, was just as direct:
“Private insurers enrolled in the Part C program purposely inflating diagnoses for financial gain is unacceptable.”
What Independence Blue Cross Says
IBX has not conceded the government’s version of events. According to trade-press coverage of the settlement, the company said it entered into the agreement to resolve a False Claims Act matter involving certain Medicare Advantage risk adjustment documentation and submission practices, and described the dispute as one involving “differing views regarding certain documentation and reporting requirements” under the risk adjustment program.
Two small details are worth noticing in how the two sides describe the case. The Justice Department frames the dispute around payment years 2017 through 2021. IBX’s own statement refers to 2016 through 2020. The two are likely describing the same stretch of conduct from different angles, since diagnoses recorded in one year generally drive the payments made the following year, but readers comparing sources will see both ranges.
Where This Fits in the Bigger Picture
IBX is described in trade coverage as the largest medical insurer in the Philadelphia area, but $22.5 million is modest compared with the biggest settlements in this category. Earlier in 2026, health plan affiliates of Kaiser Permanente agreed to pay $556 million to resolve similar upcoding allegations tied to Medicare Advantage.
The numbers around the settlement show why federal prosecutors keep returning to this area:
- About 35.2 million people, roughly 55 percent of eligible Medicare beneficiaries, are enrolled in Medicare Advantage in 2026, according to KFF
- Healthcare fraud accounted for more than $5.7 billion of the $6.8 billion in False Claims Act settlements in fiscal year 2025, according to Justice Department data
- The Justice Department says its Civil Division’s False Claims Act work supports the administration’s Task Force to Eliminate Fraud and the National Fraud Enforcement Division
The IBX matter was handled for the government by Assistant U.S. Attorney Peter Carr and litigative consultant Lauren M. Cordrey of the Eastern District of Pennsylvania, together with Civil Fraud Section attorney Wendy Zupac, with HHS-OIG supporting the investigation.
The Takeaway
The IBX settlement is not the biggest Medicare Advantage case of the year, but it may be the cleanest illustration of the issue the government keeps pressing: an insurer’s duty doesn’t stop at finding extra diagnoses that raise its payments. According to the government, it also includes acting on the findings that go the other way, and withdrawing codes that the medical records don’t support.
IBX says the case reflects a disagreement over documentation and reporting requirements. The government says the company kept money it was not owed. The settlement resolves that disagreement without a court ever deciding who was right, which is why the Justice Department’s own language remains the most accurate summary: these are allegations, and no liability has been determined.
For anyone who wants to report suspected healthcare fraud, the Justice Department points to the Department of Health and Human Services tip line at 800-HHS-TIPS (800-447-8477) and its online reporting page at oig.hhs.gov/fraud/report-fraud.ght figures all suggest the court took the underlying conduct seriously — even if the final collectible number still depends on what happens next at the appellate level.
SOURCE:
This article is based on the official Justice Department press release issued by the U.S. Attorney’s Office for the Eastern District of Pennsylvania on September 30, 2026, which was used to confirm the settlement amount, the whistleblower’s share, the case caption and number, the alleged conduct, and the statements of U.S. Attorney David Metcalf, Assistant Attorney General Brett A. Shumate and HHS-OIG’s Miranda L. Bennett. It is cross-referenced against trade and news coverage from Fierce Healthcare, Healthcare Dive, HealthExec, Law360 Healthcare Authority, the Washington Times, Hoodline and Medical Daily, which supplied Independence Blue Cross’s response, the 2016 through 2020 date range in the company’s own statement, the Kaiser Permanente comparison, and the fiscal year 2025 and KFF enrollment figures. The claims resolved by the settlement are allegations only, and there has been no determination of liability.